1129
|
Menomune
|
Meningococcal disease
|
Neisseria meningitidis
|
Polysaccharide
|
Sanofi Pasteur Inc.
|
Approved
|
Subcutaneous
|
NA
|
NA
|
1136
|
Quadri Meningo
|
Meningococcal disease
|
Neisseria meningitidis
|
Polysaccharide
|
Biomed Labs
|
Approved
|
Subcutaneous
|
NA
|
NA
|
1142
|
Pneumovax 23
|
Pneumococcal
|
Streptococcus pneumoniae
|
Polysaccharide
|
Merck & Co.
|
Approved
|
Intramuscular
|
NA
|
NA
|
1178
|
SA4AG
|
Methicillin-Resistant Staphylococcus aureus (MRSA)
|
Staphylococcus aureus
|
Polysaccharide
|
Pfizer
|
Clinical - Terminated
|
Intramuscular
|
27916408
|
NCT02388165
|
1179
|
SA3Ag
|
Methicillin-Resistant Staphylococcus aureus (MRSA)
|
Staphylococcus aureus
|
Polysaccharide
|
Pfizer
|
Clinical - Phase 1
|
Intramuscular
|
25707693
|
NCT01018641
|
1184
|
SP093
|
Salmonellosis
|
Salmonella enteritis
|
Polysaccharide
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT01608815
|
1337
|
Meningo A+C
|
Meningococcal disease
|
Neisseria meningitidis
|
Polysaccharide
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 4
|
Subcutaneous
|
NA
|
NCT01430611
|
1338
|
Meng Ling Kang
|
Meningococcal disease
|
Neisseria meningitidis
|
Polysaccharide
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 4
|
Subcutaneous
|
NA
|
NCT01430611
|
1339
|
Walvax MPV ACYW
|
Meningococcal disease
|
Neisseria meningitidis
|
Polysaccharide
|
Walvax Biotechnology Co., Ltd.
|
Clinical - Phase 4
|
Intramuscular
|
NA
|
NCT04450498
|
1342
|
ProDiax-23
|
Pneumococcal
|
Streptococcus pneumoniae
|
Polysaccharide
|
Korea University Guro Hospital
|
Clinical - Phase 4
|
Intramuscular
|
NA
|
NCT04875858
|